Biogen Cash Conversion Cycle 2011-2026 | BIIB

Annual Cash Conversion Cycle Biogen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
337	387	277	188	177	141	114	180	183	234	236	238	244	226	169

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
387	114	222

Quarterly Cash Conversion Cycle Biogen

2026-Q1	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
239	283	285	300	358	393	237	129	175	-	237	214	153	-	216	216	95.8	61.2	176	184	138	46.7	106	99.8	113	50.7	163	174	164	49.3	178	179	52.4	45.8	44.5	45.5	44.6	39.4	40.3	43.2	45	44.7	47	48.7	45.4	38.3	41.2	43.6	282	44.2	205	204	176	40.2	144	172	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
393	38.3	137

Cash Conversion Cycle of other stocks in the Biotechnology industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Biohaven Pharmaceutical Holding Company Ltd. BHVN	209	$ 9.13	-0.76 %	$ 591 M	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	-400	$ 0.91	2.42 %	$ 6.69 M	China
Edesa Biotech EDSA	97.1	$ 15.52	-2.39 %	$ 49.6 M	USA
ACADIA Pharmaceuticals ACAD	257	$ 22.47	1.19 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Fortress Biotech FBIO	-74.9	$ 2.24	0.9 %	$ 62.5 M	USA
Galapagos NV GLPG	67.1	$ 28.07	0.75 %	$ 2.69 B	Belgium
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Grifols, S.A. GRFS	0.000171	$ 8.2	3.6 %	$ 6.83 B	Spain
Harmony Biosciences Holdings HRMY	20.4	$ 31.01	-0.13 %	$ 1.78 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
ImmuCell Corporation ICCC	213	$ 8.44	-	$ 76.2 M	USA
Immuron Limited IMRN	867	$ 0.83	3.44 %	$ 6.55 M	Australia
Incyte Corporation INCY	-54.7	$ 98.87	-0.23 %	$ 19.3 B	USA
InMed Pharmaceuticals INM	184	$ 0.71	1.28 %	$ 1.74 M	Canada
INmune Bio INMB	19.9 K	$ 1.35	1.5 %	$ 33.4 M	USA
Innoviva INVA	24.6	$ 23.13	0.35 %	$ 1.56 B	USA
Aeterna Zentaris AEZS	-34.3 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Jaguar Health JAGX	289	$ 7.55	-4.13 %	$ 17.6 M	USA
KalVista Pharmaceuticals KALV	-816	$ 26.67	-0.02 %	$ 1.44 B	Britain
Kamada Ltd. KMDA	163	$ 8.15	0.49 %	$ 260 M	Israel
Ligand Pharmaceuticals Incorporated LGND	77.8	$ 223.98	-0.39 %	$ 4.1 B	USA
Liquidia Corporation LQDA	65.5	$ 38.39	0.62 %	$ 3.3 B	USA
Ampio Pharmaceuticals AMPE	-2.85 K	-	-11.43 %	$ 502 K	USA
Aquestive Therapeutics AQST	-172	$ 4.08	0.74 %	$ 436 M	USA